Vaccination has entered a "critical period", what key points need to be paid attention to?

At the State Council’s Joint Prevention and Control Mechanism press conference held on September 7, Mi Feng, spokesperson of the National Health Commission and Deputy Director of the Propaganda Department, introduced that "foreign defense import and internal non-proliferation" are still the most important aspects of current epidemic prevention and control.

Actively promote the interconnection and interoperability of the national immunization planning information system

In response to restrictive measures introduced by individual places to speed up the pace of vaccination, Wu Liangyou, deputy director of the CDC of the National Health Commission, said, “These practices violate the vaccination principle and cause inconvenience to the masses.

In response to the implementation of two-code joint inspections of health codes and vaccination codes in some areas, measures to find people who have not been vaccinated as effectively as possible.

Regarding the situation where people’s travel and life are restricted due to the large cross-regional mobility and the inability to find vaccination records, Wu Liangyou said that the vaccination unit must provide vaccination voucher for the vaccination in a timely manner after the vaccination is completed.

The elderly, children, and high-risk groups are the key targets of vaccination

At present, the new crown pneumonia epidemic continues to spread in some countries, causing the infection rate of children to continue to rise

According to reports, the overall vaccination of people aged 12 to 17 is progressing relatively smoothly, and 162.

Regarding whether the elderly need to be vaccinated, Du Xueping, director of Beijing Yuetan Community Health Service Center, believes: “The prevalence of basic diseases in the elderly is higher, and their immunity will decrease with age.

At present, the new coronavirus vaccine is still effective against various mutant strains

At the beginning of last year, China deployed 5 technical routes for the development of new coronavirus vaccines, including inactivated vaccines, adenovirus vector vaccines, recombinant protein vaccines, attenuated influenza virus vector vaccines and nucleic acid vaccines

Zheng Zhongwei emphasized that the protective effect of any vaccine against infectious diseases cannot be 100%.

Zheng Zhongwei said: “In general, the new coronavirus has not undergone fundamental mutations.

(Our newspaper, Beijing, September 7th, our newspaper reporter Jin Zhenya, our newspaper correspondent Peng Li)